PHARMAES: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
PHARMAES
Largest movements
- Cash -€16,745
down €16,745 (-83.6%), from €20,033 to €3,288
mainly Net result for the year (-€38,981) and Accrued charges and deferred income (-€312)
- Tangible fixed assets -€5,277
down €5,277 (-16.5%), from €32,059 to €26,783
of which Furniture and vehicles: -€3,864
- Deferred charges and accrued income -€4,173
down €4,173 (-27.5%), from €15,187 to €11,014
- Profit (loss) carried forward -€38,981
down €38,981 (-50.5%), from €77,260 to €38,278
- Other debts +€9,644
up €9,644 (+23533.2%), from €41 to €9,685
- Tax, wage and social debts +€2,665
up €2,665 (+391.9%), from €680 to €3,346
of which Taxes: +€1,915
- Gross operating margin -€38,668
down €38,668, from €8,252 to -€30,416
- Other operating charges -€1,932
down €1,932 (-68.3%), from €2,828 to €896
- Financial charges +€1,739
up €1,739 (+210.2%), from €827 to €2,567
- Taxes -€839
down €839 (-91.9%), from €914 to €74
- Depreciation +€307
up €307 (+6.2%), from €4,969 to €5,277
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €84,584 | €57,673 | -€26,912 | -31.8% |
| Fixed assets | 21/28 | €32,059 | €26,783 | -€5,277 | -16.5% |
| Tangible fixed assets | 22/27 | €32,059 | €26,783 | -€5,277 | -16.5% |
| Land and buildings | 22 | €18,366 | €17,732 | -€633 | -3.4% |
| Plant, machinery and equipment | 23 | €2,406 | €1,775 | -€631 | -26.2% |
| Furniture and vehicles | 24 | €6,986 | €3,122 | -€3,864 | -55.3% |
| Other tangible fixed assets | 26 | €4,302 | €4,153 | -€148 | -3.4% |
| Assets under construction and advance payments | 27 | €0 | - | = | |
| Current assets | 29/58 | €52,525 | €30,890 | -€21,635 | -41.2% |
| Amounts receivable within one year | 40/41 | €17,305 | €16,588 | -€716 | -4.1% |
| Trade receivables | 40 | €716 | - | -€716 | |
| Other amounts receivable | 41 | €16,588 | €16,588 | = | 0.0% |
| Cash at bank and in hand | 54/58 | €20,033 | €3,288 | -€16,745 | -83.6% |
| Deferred charges and accrued income | 490/1 | €15,187 | €11,014 | -€4,173 | -27.5% |
| Total equity and liabilities | 10/49 | €84,584 | €57,673 | -€26,912 | -31.8% |
| Equity | 10/15 | €82,260 | €43,278 | -€38,981 | -47.4% |
| Contributions | 10/11 | €5,000 | €5,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €77,260 | €38,278 | -€38,981 | -50.5% |
| Amounts payable | 17/49 | €2,324 | €14,394 | +€12,070 | +519.3% |
| Amounts payable within one year | 42/48 | €2,012 | €14,394 | +€12,382 | +615.4% |
| Trade debts | 44 | €1,291 | €1,364 | +€73 | +5.6% |
| Suppliers | 440/4 | €1,291 | €1,364 | +€73 | +5.6% |
| Taxes, remuneration and social security | 45 | €680 | €3,346 | +€2,665 | +391.9% |
| Taxes | 450/3 | €680 | €2,596 | +€1,915 | +281.6% |
| Remuneration and social security | 454/9 | - | €750 | +€750 | |
| Other amounts payable | 47/48 | €41 | €9,685 | +€9,644 | +23533.2% |
| Accrued charges and deferred income | 492/3 | €312 | - | -€312 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €4,969 | €5,277 | +€307 | +6.2% |
| Other operating charges | 640/8 | €2,828 | €896 | -€1,932 | -68.3% |
| Gross operating margin | 9900 | €8,252 | -€30,416 | -€38,668 | |
| Operating profit (loss) | 9901 | €454 | -€36,588 | -€37,043 | |
| Financial income | 75/76B | €6 | €248 | +€242 | +3945.7% |
| Recurring financial income | 75 | €6 | €248 | +€242 | +3945.7% |
| Financial charges | 65/66B | €827 | €2,567 | +€1,739 | +210.2% |
| Recurring financial charges | 65 | €827 | €2,567 | +€1,739 | +210.2% |
| Profit (loss) for the period before taxes | 9903 | -€367 | -€38,907 | -€38,540 | -10506.3% |
| Income taxes | 67/77 | €914 | €74 | -€839 | -91.9% |
| Profit (loss) for the period | 9904 | -€1,281 | -€38,981 | -€37,701 | -2944.2% |
| Profit (loss) for the period to be appropriated | 9905 | -€1,281 | -€38,981 | -€37,701 | -2944.2% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 9 October 2026 via checked.be.